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One-pot synthesis of doxorubicin-loaded
multiresponsive nanogels based on
hyperbranched polyglycerol†
Ana Sousa-Herves, Stefanie Wedepohl and Marcelo Caldero´n*
Doxorubicin-loaded nanogels with multiresponsive properties are
prepared using hyperbranched polyglycerol as a biocompatible
scaﬀold. The nanogels are synthesized in a single step combining
free-radical polymerization and a mild nanoprecipitation technique.
The nanogels respond to diﬀerent biological stimuli such as low
pH and reductive environments, resulting in a more eﬃcient cell
proliferation inhibition in A549 cells.
Recent advances in nanomedicine have prompted the need to
develop delivery systems that can encapsulate a variety of novel
therapeutics. The ideal drug delivery system should be bio-
degradable and biocompatible, target only the desired cells and
tissue, and release their cargo at the intracellular space.1,2 Moreover,
these nanocarriers should be smart so that they can deliver their
payload at a well-defined time, place, or after a specific stimulus.3,4
Selected examples of biological stimuli include pH, temperature,
and redox microenvironments.3,5 pH-sensitiveness can be exploited
for selective drug release at the slightly acidic pH of tumors and/or
at the more acidic cellular compartments endosome/lysosome.
Complementary, redox sensitivity can trigger the cytosolic release
of drugs due to the diﬀerent concentrations of glutathione (GSH)
in extracellular and intracellular compartments.
Among the diﬀerent nanostructures employed in drug delivery,
polymeric nanogels (NGs) have recently attracted a great deal of
attention.6–10 NGs are a type of crosslinked, nanometric-sized
hydrogel particles. They have a tunable size and a large surface area
for multivalent bioconjugation and can incorporate therapeutics in
their interior network. The entrapment of bioactive molecules
(including anticancer drugs, proteins, and nucleic acids) in NGs
as well as their in vitro release has been extensively investigated.6–10
The advantages of NGs over other drug delivery systems include
their large water content, soft nature, high loading capacity,
and stability of the resulting dispersion. Moreover, NGs can be
engineered to provide optimal loading and release of drugs. In this
context, the groups of Haag and Caldero´n have recently reported
the preparation of NGs using hyperbranched polyglycerol (hPG) as
a biocompatible, multifunctional scaffold.11–13 It is noteworthy
that hPG14,15 has been shown to be even less cytotoxic than the
structurally similar and FDA-approved polyethylene glycol.16,17
Although there are several reports on smart NGs,4,18,19 the pre-
paration of multi-stimuli responsive NGs loaded with anticancer
drugs11,20,21 is usually relatively complex and requires high shear
stress (such as ultrasonication or high-pressure homogenization
used in miniemulsion), multiple purification steps, and encapsu-
lation of the drug after NG formation.22
Herein, we present an eﬃcient one-pot approach for preparing
multiresponsive NGs that have been loaded with the anticancer drug
doxorubicin (DOX) and employ hPG as a biocompatible scaﬀold.We
have incorporated a pH-sensitive-monomer and a redox-responsive
crosslinker into the NGs structure to give them stimuli-responsive
properties. The NGs have been synthesized by free radical
polymerization in combination with a nanoprecipitation23
technique to template NG formation during the polymerization
process (Scheme 1). To the best of our knowledge, this is the
first example of NG preparation by nanoprecipitation employing
free radical polymerization.
First the bulk hydrogels were prepared in order to check the
chemical compatibility and suitability of the system. The success
of macrogel formation encouraged us to synthesize the gels with
sizes in the nanometer scale. Unloaded NGs were prepared first
in order to establish the synthetic conditions and to optimize the
desired multiresponsive properties. Monomethyl oligo(ethylene
glycol)acrylate (OEGA) and pH-responsive 2-(5,5-dimethyl-1,3-
dioxan-2-yloxy)ethyl acrylate DMDEA20,24 were selected asmonomers.
Redox-responsive bis(2-methacryloyl)oxyethyl disulfide (BMADS) was
employed as the crosslinker while acrylated hPG (hPG-Ac, 35%
functionalization) was chosen as a macro-crosslinker (Scheme 1).
NGs were synthesized by free radical polymerization using a
nanoprecipitation approach to template gel formation. The
nanoprecipitationmethod involves particle formation by injection
of the monomers and crosslinker solution into a non-solvent,
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and a simultaneous formation of a colloidal suspension caused
by diﬀusion of the solvent into the non-solvent.23 This technique
has been traditionally employed for the preparation of nano-
particles from previously synthesized polymers, in particular
from poly(lactic acid) and its copolymers. More recently, we and
others have exploited inverse nanoprecipitation in water/acetone11,12
and thermo-nanoprecipitation13 for the preparation of NGs via
chemical crosslinking of preformed polymeric scaﬀolds. In this
work, nanoprecipitation was employed for the first time to
prepare NGs comprising chain-growth polymerization.
Therefore hPG was highly functionalized with acrylate groups in
order to obtain a derivative with similar solubility to hydrophobic
DMDEA and BMADS. DMF was employed as the solvent and an
aqueous solution of phosphate buﬀer (PB, 50mMpH 8) as the non-
solvent. Sodium dodecyl sulfate (SDS) was used as surfactant and
AIBN as the organo-soluble initiator for the radical polymerization.
The monomers, crosslinkers, and initiator were dissolved in DMF
and subsequently precipitated into the non-solvent. The oxygen was
then removed and the reaction temperature was increased to 65 1C
to start the polymerization. The resulting NGs were extensively
purified by dialysis in PB 10 mM pH 8 and stored at 4 1C. Detailed
synthetic conditions are described in the ESI.†
Several synthetic parameters were screened in order to obtain a
suitable system for biological applications, i.e., with an adequate
size, stability and low polydispersity (PDI). As a result, DMF and
MeOH were tested as the solvent, whereby DMF turned out to be
more suitable (in terms of particle size and stability) in a solvent/
non-solvent ratio of 1 : 20. The influence of monomers and cross-
linkers concentration as well as the monomer’s feed-ratio in the
NGs sizes was also studied (Table S1, ESI†). Interestingly, raising
the hPG concentration from 12.5% to 25% (weight%) only resulted
in a small increase in the NG’s size from 87 to 97 nm, as measured
by dynamic light scattering (DLS). More importantly, employing
the synthetic conditions reported in this work, NGs could not be
obtained when hPG was not present. This suggests that the role of
the hyperbranchedmacromolecule in the nanoprecipitation process
is very important. In addition, a significant increase in the NG’s size
(87 vs. 176 nm, by DLS) could be observed when the ratio between
hydrophobic DMDEA and hydrophilic OEGA was increased. NG 3 in
Table S1 (ESI†) was selected as the optimal NG formulation because
of its higher concentration and appropriate size. As shown in
Fig. 1a, DLS measurements for NG 3 revealed a hydrodynamic size
of ca. 87 nm and a low PDI (0.11). Atomic force microscopy (AFM)
demonstrated the presence of spherical, uniformly distributed
particles with a mean diameter of 45 nm (Fig. 1b). The smaller
value observed in AFM can be attributed to the partial deswelling
of the particles on the mica surface, as previously reported for
other hydrophilic NGs.13,25
The progress of free radical polymerization could be easily
monitored by the disappearance of the acrylate and methacrylate
peaks (5.5–6.5 ppm) and the appearance of the peaks corresponding
to the polymeric backbone in the 1H NMR spectrum (Fig. S1, ESI†).
The OEGA peaks could be observed by NMR, which confirmed that
OEGA did not diffuse to the aqueous phase during the polymeriza-
tion. The hPG peaks could not be clearly seen because they over-
lapped with those of DMDEA and OEGA, but their presence within
the NG is ensured by the fact that NGs do not form if hPG is not
included in the formulation. As a comparison, 1H NMR spectrum of
NG 5 (lacking DMDEA monomer) is included in the ESI† (Fig. S2).
In addition, FT-IR spectroscopy of the freeze-dried NGs supported
the lack of acrylate groups in the NGs (Fig. S3, ESI†).
The multiresponsive behavior of the NGs was studied by DLS
and AFM. Lowering the pH from 8 to 5 resulted in a huge
increase in the size of NG 3 (from 87 to 200 nm), due to hydrolysis
of the orthoester groups in DMDEA units, which led to more
hydrophilic moieties and prompted the swelling of the NGs
(Fig. 2a). The PDI of the hydrolyzed NGs was, nevertheless, quite
low (0.16), probably because the hydrolysis of one of the mono-
mers did not aﬀect the integrity of the crosslinked polymeric
network. AFM images of the hydrolyzed NGs further confirmed
the increase in the mean size (166 nm, Fig. 2a). Notably, such an
eﬀect was not observed for the control NG 5, which lacks DMDEA
monomer. In addition, the disappearance of the peak at 5.5 ppm
in the 1H NMR, which corresponds to the orthoester group,
proved the hydrolysis of the NGs.
Similarly, the presence of the reductive agent dithiothreitol
(DTT) produced an important increase in the sizes and PDI of
Scheme 1 Preparation of multiresponsive NGs and proposed mechanism
of action.
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the NGs (183 nm, PDI 0.26, Fig. 2b), which can be attributed to
reduction-cleavage of one of the crosslinkers’ disulfide bonds.
In this case, the higher PDI values arose from the destabiliza-
tion of the polymeric network. It is important to note that NGs
did not completely decompose because the presence of the
macro-crosslinker hPG preserves part of the polymeric network.
This feature (high increase in size and PDI) can be exploited to
achieve post-endocytic nanogel destabilization and drug release,
due to the large intra/extracellular redox gradient present in most
cells. Again, control NG 7, which lacked BMADS, did not show any
sign of destabilization when treated under identical circumstances.
Remarkably, the combination of OEGA with more hydrophobic
monomers is known to present thermoresponsive properties,
and has been employed by several groups for the preparation of
thermosensitive nanogels.20,26 Indeed, we observed an aggregation
behavior for the NGs by DLS (presence of particles 41000 nm)
when the temperature was increased from 25 to 55 1C. This process
was completely reversible and the aggregates disappeared when the
temperature was lowered back to 25 1C. Unfortunately, the cloud
point for the NGs could not be obtained by typical turbidity
experiments at diﬀerent temperatures. In order to deeply investi-
gate the sensitivity of NG 3 towards temperature, we employed
nanoparticle tracking analysis (NTA). NTA was performed in highly
diluted solutions (0.01–0.001 mg mL1), which at the same time
confirmed the stability of the NGs upon dilution, an important fact
when intravenous applications are considered. NTA measurements
showed that the number of particles decreased by 40% when
temperature was increased from 25 to 55 1C (from 3.62 
108 particles per mL to 2.23  108 particles per mL), however,
the main size of the particles remained in the same size range
(101 and 109 nm, respectively). Taking into account the informa-
tion obtained by DLS and NTA, we hypothesize that the NGs rapidly
shrink when the temperature reaches a certain value, which leads
to a reversible aggregation of the resulting smaller particles.
With a reliable and simple method for the preparation of
multiresponsive NGs in hand, we decided to go a step further
and incorporate the anticancer drug DOX during NG synthesis.
NGs were basically prepared as described above but included
non-protonated DOX in the DMF solution (detailed synthetic
conditions in the ESI†). Commonly employed DOXHCl could not
be incorporated due to hydrolysis of the NGs under acid conditions.
Ideally, the drug would interact with macromolecular hPG and the
monomers when injected into the non-solvent, leading to its
entrapment within the crosslinked NG. This methodology allows
the production of NGs containing an anticancer drug in one
single step, thus avoiding tedious post-encapsulation and purifica-
tion processes. In addition, the incorporation of the drug during
the nanoprecipitation process enabled higher encapsulation eﬃci-
encies. Thus, the maximum amount of DOX that was reached
when the drug was post-encapsulated within unloaded NGs was
5% (weight%, data not shown), while values of 10% could be
achieved by the one-pot approach.
DOX-loaded NGs were characterized by FT-IR and DLS. DLS
showed a slight increase in size (115 nm) and a low PDI (0.12).
In the case of the control NGs that lacked one of the responsive
moieties, sizes and PDIs varied significantly (Table 1). DOX-
loaded NGs were purified using a centrifugal filter device
followed by dialysis in PB buﬀer 10 mM pH 8. After purification,
NGs were analysed by size exclusion chromatography using
Sephadex G25 gel to verify that there was no free drug. The NGs
were freeze-dried and the DOX content was determined by
UV-Vis measurements in DMSO/H2O (9 : 1) (l = 503 nm) after
performing a calibration curve (Fig. S4, ESI†). In the case of NGs
containing all monomers, DOX quantification can also be
performed in H2O (Fig. S6a, ESI†). Notably, DOX loading in
the diﬀerent NGs varied significantly. For example, the NG
lacking BMADS displayed a much lower drug content. This
might be explained by the less compact polymeric network for
this NG, which would have facilitated the diﬀusion of the drug
during the purification steps.
In order to prove DOX stability under free radical polymeri-
zation environment, free DOX was treated under NG formation
conditions, purified, and analysed by HPLC and mass spectro-
metry. The expected mass ([M + Na + 2H]+: 568.14) was found in
the mass spectrum, while HPLC chromatograms revealed the
same retention time for treated-DOX, untreated DOXHCl, and
deprotonated untreated-DOX (Fig. S5, ESI†).
In vitro DOX release was analysed for the NGs at diﬀerent
pH values and in the presence of the reducing agent DTT.
Notably, an accelerated drug release for the NG containing all
monomers and crosslinkers was observed at pH 5 in the presence
of 20 mM DTT. Thus, approx. 95% of DOX was released after 8 h,
while only 20% of free drug could be observed for the same
incubation time at pH 8 (Fig. S6b, ESI†).
The cytotoxicity and internalization of the NGs in A549 lung-
carcinoma cells was then investigated. MTT assays showed an IC50
value of ca. 1 mg mL1 for unloaded NGs (Fig. S7a, ESI†). However,
no eﬀect on cell proliferation and morphology was observed in
real time cell analysis (RTCA, Fig. S8, ESI†) at a concentration of
0.54 mg mL1, which corresponds to 100 mM DOX in the drug-
loaded NGs. Considering the high cytotoxicity of DOX at such
concentration, the NGs appear to be suitable drug carrier candidates.
Cell proliferation inhibition of DOX-loaded NGs was studied
by RTCA and MTT assays and finally compared to free DOX
Fig. 2 (a) Intensity size distribution of NG 3 at pH 8 and at pH 5. AFM
image of a hydrolyzed NG (3.8  3.8 mm). (b) Intensity size distribution of
NG 3 (w/o DTT) and in the presence of 20 mM DTT.
Table 1 Features of DOX-loaded NGs
Nanogel Size (nm) PDI DOX loading (wt%)
All monomers 115 0.12 10
w/o DMDEA 287 0.4 10
w/o OEGA 146 0.29 8
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(Fig. 3, Fig. S7b and S8, ESI†). Fig. 3 shows the inhibition of
cell proliferation at a concentration of 10 mM DOX (for dose-
response curves see Fig. S7b, ESI†). DOX-loaded NGs containing
all monomers caused a reduction of viability to 27% on average,
which was the closest to free DOX (18%). NGs without OEGA,
BMADS or DMDEA caused significantly less reduction, with mean
values of 38%, 39% and 33.6%, respectively. When the eﬀect of
the DOX-loaded NGs on the morphology and proliferation of
cancer cells was analysed in real time, the NGs with all monomers
showed again the most similar profile to that of free DOX (Fig. S8,
ESI†). The NGs lacking any of the responsive moieties were less
eﬀective and presented very dissimilar profiles, suggesting that
the combination of the diﬀerent stimuli in the multiresponsive
NGs may have a synergistic eﬀect.
Finally, internalization of the DOX-loaded NGs (all monomers)
into A549 cells was studied by confocal laser scanning micro-
scopy (Fig. 4 and Fig. S9, ESI†). After 2 h of incubation, the NGs
were accumulated in the endosomes/lysosomes (co-localization
with LysoTracker), and some DOX fluorescence could be detected
in the cytoplasm.
We have developed a simple, reproducible, one-pot synthetic
approach that allows the preparation of DOX-loaded multi-
responsive NGs based on biocompatible hPG. This strategy
combines free radical polymerization, nanoprecipitation, and
high-loading drug encapsulation in a single step. The method
here described could be applied for the in situ encapsulation
of other drugs or bioactive molecules into NGs prepared by
polymerization processes. Unloaded NGs were first prepared
and their multiresponsive properties were analysed in vitro and
compared with the corresponding controls. The NGs showed a
high increase in their sizes and PDI in the presence of acidic pH
and DTT, which can be exploited for intracellular drug release.
DOX-loaded NGs (containing all monomers or lacking any of the
responsive moieties) were prepared and their relative perfor-
mances in cell proliferation inhibition were studied. The diﬀerent
cytotoxicity profiles obtained in MTT assays and RTCA suggest the
presence of a synergistic eﬀect for the multiresponsive NGs.
Finally, confocal microscopy studies revealed that DOX-loaded
NGs were eﬃciently internalized by A549 cancer cells.
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